Kami menyediakan berita terkini dari dunia ekonomi dan kewangan
(RTTNews) - AbbVie (ABBV) revealed earnings for its first quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $1.37 billion, or $0.77 per share. This compares with $239 million, or $0.13 per share, in last year's first quarter.
Excluding items, AbbVie reported adjusted earnings of $4.12 billion or $2.31 per share for the period.
Analysts on average had expected the company to earn $2.23 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 0.7% to $12.31 billion from $12.23 billion last year.
AbbVie earnings at a glance (GAAP) :
-Earnings (Q1): $1.37 Bln. vs. $239 Mln. last year. -EPS (Q1): $0.77 vs. $0.13 last year. -Revenue (Q1): $12.31 Bln vs. $12.23 Bln last year.
-Guidance: Full year EPS guidance: $11.13 - $11.33
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd diberi kuasa dan dikawal selia oleh Suruhanjaya Sekuriti dan Bursa Cyprus mengikut lesen No.281/15 yang dikeluarkan pada 25/09/2015. Tanda dagangan "Just2Trade" dimiliki oleh LimeTrading (CY) Ltd.
Nombor Pendaftaran: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Penafian:
Semua promosi, bahan dan maklumat laman web ini mungkin telah dikenakan syarat.
Sila hubungi syarikat untuk maklumat lanjut.
Dagangan di pasaran kewangan membawa risiko.Nilai pelaburan boleh meningkat dan menurun dan pelabur mungkin kehilangan semua modal pelaburan mereka.Dalam kes produk yang dimanfaatkan, kerugian mungkin lebih daripada modal awal yang dilaburkan. Maklumat terperinci mengenai risiko yang berkaitan dengan perdagangan di pasaran kewangan boleh didapati dalam pendedahan risiko penuh..